These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3972800)

  • 41. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ; Bodley JW
    J Biol Chem; 1981 Aug; 256(16):8579-81. PubMed ID: 6267047
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B; Rattan SI; Clark BF
    J Biochem Biophys Methods; 1989 Oct; 19(4):319-25. PubMed ID: 2693515
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanism of action of Pseudomonas aeruginosa exotoxin Aiadenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo.
    Iglewski BH; Liu PV; Kabat D
    Infect Immun; 1977 Jan; 15(1):138-44. PubMed ID: 188760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products.
    Van Ness BG; Howard JB; Bodley JW
    J Biol Chem; 1980 Nov; 255(22):10717-20. PubMed ID: 7000782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of diphthamide synthesis by 5'-deoxy-5'-methylthioadenosine in murine lymphoma cells.
    Yamanaka H; Kajander EO; Carson DA
    Biochim Biophys Acta; 1986 Sep; 888(2):157-62. PubMed ID: 3091083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA; Davydova EK; Sitikov AS; Vertiev IuA; Ezepchuk IuV
    Dokl Akad Nauk SSSR; 1984; 278(3):751-4. PubMed ID: 6209075
    [No Abstract]   [Full Text] [Related]  

  • 49. Purification of elongation factor 2 from human placenta and evidence of its fragmentation patterns in various eukaryotic sources.
    Giovane A; Servillo L; Quagliuolo L; Balestrieri C
    Biochem J; 1987 Jun; 244(2):337-44. PubMed ID: 3663126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular ADP-ribosylation of elongation factor 2.
    Iglewski WJ
    Mol Cell Biochem; 1994 Sep; 138(1-2):131-3. PubMed ID: 7898455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quantification of diphtheria toxin mediated ADP-ribosylation in a solid-phase assay.
    Bachran C; Sutherland M; Bachran D; Fuchs H
    Clin Chem; 2007 Sep; 53(9):1676-83. PubMed ID: 17712004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mechanism of ADP-ribosylation of elongation factor 2 catalyzed by fragment A from diphtheria toxin.
    Chung DW; Collier RJ
    Biochim Biophys Acta; 1977 Aug; 483(2):248-57. PubMed ID: 196649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diphtheria toxin translocation across endosome membranes. A novel cell permeabilization assay reveals new diphtheria toxin fragments in endocytic vesicles.
    Umata T; Mekada E
    J Biol Chem; 1998 Apr; 273(14):8351-9. PubMed ID: 9525944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Site-specific mutagenesis of the histidine precursor of diphthamide in the human elongation factor-2 gene confers resistance to diphtheria toxin.
    Ivankovic M; Rubelj I; Matulic M; Reich E; Brdar B
    Mutat Res; 2006 Oct; 609(1):34-42. PubMed ID: 16901746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
    Galicka A; Sredzińska K; Gindzieński A
    Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diphtheria toxin.
    Uchida T
    Pharmacol Ther; 1982; 19(1):107-22. PubMed ID: 6763703
    [No Abstract]   [Full Text] [Related]  

  • 57. Actin--an inhibitor of eukaryotic elongation factor activities.
    Bektaş M; Günçer B; Güven C; Nurten R; Bermek E
    Biochem Biophys Res Commun; 2004 May; 317(4):1061-6. PubMed ID: 15094376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties.
    Bodley JW; Dunlop PC; VanNess BG
    Methods Enzymol; 1984; 106():378-87. PubMed ID: 6387379
    [No Abstract]   [Full Text] [Related]  

  • 59. Primary structure of elongation factor 2 around the site of ADP-ribosylation is highly conserved from archaebacteria to eukaryotes.
    Gehrmann R; Henschen A; Klink F
    FEBS Lett; 1985 Jun; 185(1):37-42. PubMed ID: 3996598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EFFECT OF DIPHTHERIA TOXIN T-DOMAIN ON ENDOSOMAL pH.
    Labyntsev AJ; Korotkevych NV; Kolybo DV; Komisarenko SV
    Ukr Biochem J; 2015; 87(4):13-23. PubMed ID: 26547959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.